GXAI vs VRTX · rev $1.9M vs P/E 30, rev $3.33B
Gaxos.ai Inc (GXAI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Gaxos.ai Inc (GXAI) is a electronic gaming & multimedia company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US. It is led by Reshma Kewalramani FASN, M.D..
Latest reported GXAI revenue for 2025-12-31 was $1.9M. Net income was -$3.9M. Revenue was up 47901.7% from 2024-12-31 to 2025-12-31. GXAI currently screens at market cap $12.3M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
GXAI currently screens at market cap $12.3M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the GXAI and VRTX stock pages for the full models.
Not investment advice.